Evofem Biosciences, Inc.:
Amphora: Multipurpose Vaginal pH Regulator (MVP-R) being developed as a non-hormonal, on-demand, woman-controlled contraceptive vaginal gel; currently completing confirmatory Ph 3 in 1400 women in US. Reported top-line data in Dec 2018, 1H 2019 NDA submission; potential US launch 1Q 2020.
12400 High Bluff Drive
San Diego, CA 92130
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Upcoming Company Event Participation
Class of 2018 Biotech IPOs Investor Day
Davis Polk Event Space,
April 26, 2019
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by